Masthead
6 November 2020
Instructions to Authors
6 November 2020
Hepatology Highlights
Nicholas W. Russo, Robert S. Brown, Gopanandan Parthasarathy, Robert E. Schwartz, Adam Buckholz, Arun B. Jesudian, Enis Kostallari, Cesar Taborda, Joel Wedd, Tejasav S. Sehrawat, Navid Hejazifar, Lauren M. Yang, Daryl T.Y. Lau, Jessica Maiers, Nidhi Jalan‐Sakrikar – 6 November 2020
Current Concepts in Coagulation Profile in Cirrhosis and Acute‐on‐Chronic Liver Failure
Madhumita Premkumar, Shiv Kumar Sarin – 5 November 2020
Use of Blood Products and Drugs Before Procedures in Patients With Cirrhosis
Achintya D. Singh, Shalimar – 5 November 2020
Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg‐Negative CHB
Maximilian Wübbolding, Juan Carlos Lopez Alfonso, Chun‐Yen Lin, Sebastian Binder, Christine Falk, Jennifer Debarry, Paul Gineste, Anke R.M.
Contrast‐Enhanced Ultrasonography–Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver Failure
Hidekatsu Kuroda, Tamami Abe, Yudai Fujiwara, Tomoaki Nagasawa, Yuji Suzuki, Keisuke Kakisaka, Yasuhiro Takikawa – 5 November 2020
Addressing Social Determinants of Liver Disease During the COVID‐19 Pandemic and Beyond: A Call to Action
Ani Kardashian, Julius Wilder, Norah A. Terrault, Jennifer C. Price – 4 November 2020 – The COVID‐19 pandemic has exposed healthcare inequities in the USA and highlighted the importance of social conditions in shaping the health of persons. In the field of hepatology, social determinants of health (SDOH) are closely linked to disparities in liver disease prevalence, outcomes, and access to treatment.
Use of Blood Products and Drugs Before Procedures in Patients With Cirrhosis
Achintya D. Singh, Shalimar – 3 November 2020
CON: Portal Vein Thrombosis Does Not Impact Liver Transplantation Outcomes
Courtney Sherman, Shareef Syed, James Gardner, Francis Y. Yao – 3 November 2020